Resources

Ontario’s Community-Dwelling Older Adults Who Remain Unvaccinated Against COVID-19

Product: — Science Table

Barriers to Access Health Inequities Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: July 16, 2021

Strategies to Support Ontarians’ Capability, Opportunity, and Motivation for COVID‑19 Vaccination

Product: — Science Table

About Coronavirus Epidemiology Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: June 23, 2021

Guidance and Jurisdictional Evidence Regarding The Use of Vaccine Passports

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: June 21, 2021

Effectiveness of Incentives to Promote COVID‑19 Vaccine Uptake

Product: — Evidence Synthesis Network

Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: June 17, 2021

COVID-19 Vaccination for People with Disabilities

Product: — Science Table

Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Last Updated: June 15, 2021

Lessons Learned from Israel’s Reopening During a Nationwide COVID‑19 Vaccination Campaign

Product: — Science Table

About Coronavirus Business Re-opening Epidemiology Re-Opening

covid19-sciencetable.ca Last Updated: May 31, 2021

Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Product: — Cochrane Library

Drug Interventions Immune System Treatments Vaccines & Immunity

www.cochranelibrary.com Last Updated: May 20, 2021

Also available in Français

COVID-19 Post-Vaccine Risks, Activities, and Public Health Measures

Product: — Evidence Synthesis Network

Public Health Policy Regulation & Policy Vaccine Vaccines & Immunity

esnetwork.ca Last Updated: May 12, 2021

The Impact of Reopening and the Lifting of COVID‑19 Restrictions

Product: — Evidence Synthesis Network

Public Health Policy Re-Opening Regulation & Policy

esnetwork.ca Last Updated: May 12, 2021

Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines

Product: — Science Table

Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity

covid19-sciencetable.ca Last Updated: May 11, 2021